financetom
Business
financetom
/
Business
/
US court denies Musk preliminary injunction in his suit against OpenAI
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US court denies Musk preliminary injunction in his suit against OpenAI
Mar 4, 2025 5:34 PM

March 4 (Reuters) - A U.S. court on Tuesday denied

billionaire entrepreneur Elon Musk a preliminary injunction he

was seeking against ChatGPT-maker OpenAI's efforts to convert

into a for-profit firm.

(Reporting by Gnaneshwar Rajan in Bengaluru; Editing by Varun H

K)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Temu Parent PDD Warns Current Profits Not Sustainable As Competition Heats Up In China
Temu Parent PDD Warns Current Profits Not Sustainable As Competition Heats Up In China
Aug 25, 2025
Temu parent PDD Holdings ( PDD ) stock is trading higher on Monday after the company reported fiscal second-quarter 2025 results. Revenue grew 7% year-on-year (Y/Y) to $14.52 billion (103.98 billion Chinese yuan), topping the analyst consensus estimate of $14.35 billion. During the earnings conference call, PDD executives highlighted steady growth in retail sales and expressed strong confidence in the long-term potential of China's consumer market. Also Read: PDD Margins Fall On...
Swiss Post to temporarily suspend goods consignments to US
Swiss Post to temporarily suspend goods consignments to US
Aug 25, 2025
ZURICH, Aug 25 (Reuters) - Swiss Post said on Monday it would from Tuesday temporarily suspend accepting goods consignments to the United States due to new U.S. customs regulations. Swiss Post is working on solutions to ensure goods consignments can be shipped again as soon as possible, it said in a statement, noting that the new U.S. regulations were affecting...
BRIEF-Abbvie To Acquire Gilgamesh Pharmaceuticals' Bretisilocin
BRIEF-Abbvie To Acquire Gilgamesh Pharmaceuticals' Bretisilocin
Aug 25, 2025
Aug 25 (Reuters) - Abbvie Inc ( ABBV ): * ABBVIE TO ACQUIRE GILGAMESH PHARMACEUTICALS' BRETISILOCIN, A NOVEL, INVESTIGATIONAL THERAPY FOR MAJOR DEPRESSIVE DISORDER, EXPANDING PSYCHIATRY PIPELINE * ABBVIE INC ( ABBV ) - TO BUY BRETISILOCIN PROGRAM FOR UP TO $1.2 BILLION * ABBVIE ( ABBV ) - GILGAMESH WILL SPIN OFF A NEW ENTITY THAT WILL OPERATE UNDER...
Intel Secures $8.9 Billion Investment From US Government for 9.9% Equity Stake
Intel Secures $8.9 Billion Investment From US Government for 9.9% Equity Stake
Aug 25, 2025
09:03 AM EDT, 08/25/2025 (MT Newswires) -- Intel ( INTC ) shares rose early Monday following the company's announcement last week that the US government agreed to acquire a 9.9% stake in the chipmaker, as part of an $8.9 billion investment deal with the Trump administration. The US government will purchase 433.3 million shares of Intel ( INTC ) at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved